Xuejun Jin

3.6k total citations
91 papers, 3.0k citations indexed

About

Xuejun Jin is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xuejun Jin has authored 91 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 32 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Xuejun Jin's work include Cancer, Hypoxia, and Metabolism (18 papers), Natural product bioactivities and synthesis (11 papers) and Ubiquitin and proteasome pathways (10 papers). Xuejun Jin is often cited by papers focused on Cancer, Hypoxia, and Metabolism (18 papers), Natural product bioactivities and synthesis (11 papers) and Ubiquitin and proteasome pathways (10 papers). Xuejun Jin collaborates with scholars based in China, South Korea and Japan. Xuejun Jin's co-authors include Juan Ma, Jung Joon Lee, Lian Xun Piao, Ming Yue Li, Hong Xiang Zuo, Yue Xing, Young‐Soo Hong, Cheng Hua Jin, Jing Ying Wang and Kyeong Lee and has published in prestigious journals such as Analytical Chemistry, Chemical Communications and Journal of Agricultural and Food Chemistry.

In The Last Decade

Xuejun Jin

88 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuejun Jin China 34 1.6k 630 374 322 310 91 3.0k
Duan‐Fang Liao China 30 2.2k 1.4× 734 1.2× 349 0.9× 470 1.5× 215 0.7× 120 3.9k
Xun Hu China 39 2.6k 1.6× 957 1.5× 525 1.4× 319 1.0× 394 1.3× 83 4.3k
Andrzej Stepulak Poland 30 1.8k 1.1× 481 0.8× 389 1.0× 193 0.6× 169 0.5× 112 3.0k
Xiaozhuo Chen United States 27 2.1k 1.3× 932 1.5× 560 1.5× 197 0.6× 237 0.8× 73 3.6k
Jeong‐Hyung Lee South Korea 32 2.3k 1.5× 501 0.8× 376 1.0× 399 1.2× 207 0.7× 103 3.6k
Acharan S. Narula India 27 1.6k 1.0× 413 0.7× 344 0.9× 326 1.0× 474 1.5× 96 3.4k
Gyu‐Yong Song South Korea 37 2.2k 1.4× 367 0.6× 356 1.0× 321 1.0× 480 1.5× 172 3.7k
Takeshi Kumagai Japan 26 1.5k 1.0× 446 0.7× 208 0.6× 370 1.1× 384 1.2× 91 3.1k
Xiaojun Xu China 32 1.5k 0.9× 349 0.6× 277 0.7× 211 0.7× 135 0.4× 83 2.9k

Countries citing papers authored by Xuejun Jin

Since Specialization
Citations

This map shows the geographic impact of Xuejun Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuejun Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuejun Jin more than expected).

Fields of papers citing papers by Xuejun Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuejun Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuejun Jin. The network helps show where Xuejun Jin may publish in the future.

Co-authorship network of co-authors of Xuejun Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Xuejun Jin. A scholar is included among the top collaborators of Xuejun Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuejun Jin. Xuejun Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yi, Tai, Hong Xiang Zuo, Yue Xing, et al.. (2025). Formononetin ameliorates DSS-induced colitis by inhibiting the MAPK/PPAR-γ/NF-κB/ROS signaling pathways. Toxicology and Applied Pharmacology. 496. 117239–117239. 6 indexed citations
2.
Ri, MyongHak, Yue Xing, Hong Xiang Zuo, et al.. (2023). Regulatory mechanisms of natural compounds from traditional Chinese herbal medicines on the microglial response in ischemic stroke. Phytomedicine. 116. 154889–154889. 20 indexed citations
3.
Zhong, Yi, Ming Yue Li, Yi‐Yin Tai, et al.. (2023). Galangin inhibits programmed cell death-ligand 1 expression by suppressing STAT3 and MYC and enhances T cell tumor-killing activity. Phytomedicine. 116. 154877–154877. 10 indexed citations
4.
Zhang, Huamin, Shuo Yuan, Huan Meng, et al.. (2022). Stem Cell-Based Therapies for Inflammatory Bowel Disease. International Journal of Molecular Sciences. 23(15). 8494–8494. 32 indexed citations
5.
Jin, Cheng Hua, et al.. (2021). New role of sertraline against Toxoplasma gondii ‐induced depression‐like behaviours in mice. Parasite Immunology. 43(12). e12893–e12893. 9 indexed citations
6.
Ri, MyongHak, Juan Ma, & Xuejun Jin. (2021). Development of natural products for anti-PD-1/PD-L1 immunotherapy against cancer. Journal of Ethnopharmacology. 281. 114370–114370. 31 indexed citations
7.
Xing, Yue, Mingyue Li, Zhihong Zhang, et al.. (2021). Licochalcone A inhibits proliferation and promotes apoptosis of colon cancer cell by targeting programmed cell death-ligand 1 via the NF-κB and Ras/Raf/MEK pathways. Journal of Ethnopharmacology. 273. 113989–113989. 61 indexed citations
8.
Wang, Jing Ying, Ming Yue Li, Zhi Hong Zhang, et al.. (2021). Formononetin represses cervical tumorigenesis by interfering with the activation of PD-L1 through MYC and STAT3 downregulation. The Journal of Nutritional Biochemistry. 100. 108899–108899. 46 indexed citations
9.
Wang, Da‐Yuan, Yanwei Li, Linhao Zhang, et al.. (2020). Synthesis and evaluation of HIF-1α inhibitory activities of novel panaxadiol derivatives. Bioorganic & Medicinal Chemistry Letters. 30(24). 127652–127652. 4 indexed citations
10.
11.
Zhao, Xudong, Xiang Xu, Fumie Aosai, et al.. (2020). Arctigenin exhibits hepatoprotective activity in Toxoplasma gondii-infected host through HMGB1/TLR4/NF-κB pathway. International Immunopharmacology. 84. 106539–106539. 24 indexed citations
12.
Li, Yanwei, Xiangyü Li, Limin Zhao, et al.. (2019). Synthesis and evaluation of the HIF-1α inhibitory activity of 3(5)-substituted-4-(quinolin-4-yl)- and 4-(2-phenylpyridin-4-yl)pyrazoles as inhibitors of ALK5. Bioorganic & Medicinal Chemistry Letters. 30(2). 126822–126822. 17 indexed citations
13.
Jiang, Zhe, Mei Jin, Wei Zhou, et al.. (2018). Anti-Inflammatory Activity of Chemical Constituents Isolated from the Willow Bracket Medicinal Mushroom Phellinus igniarius (Agaricomycetes). International journal of medicinal mushrooms. 20(2). 119–128. 10 indexed citations
14.
Jin, Mei, Changhao Zhang, Jie Luo, et al.. (2014). A new phenyl glycoside from the aerial parts ofEquisetum hyemale. Natural Product Research. 28(21). 1813–1818. 11 indexed citations
15.
Wang, Hui, Hongying An, Bin Wang, et al.. (2013). miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway. European Journal of Cancer. 49(18). 3924–3935. 96 indexed citations
16.
Zhou, Xin, Xuejun Jin, Donghao Li, & Xue Wu. (2011). Selective detection of zwitterionic arginine with a new Zn(ii)-terpyridine complex: potential application in protein labeling and determination. Chemical Communications. 47(13). 3921–3921. 42 indexed citations
17.
Won, Misun, Soo-Hyun Park, Shanthaveerappa K. Boovanahalli, et al.. (2009). A novel benzimidazole analogue inhibits the hypoxia-inducible factor (HIF)-1 pathway. Biochemical and Biophysical Research Communications. 385(1). 16–21. 51 indexed citations
18.
Jin, Xuejun, Hong Jin, Dongho Lee, et al.. (2008). A quassinoid 6α-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation. European Journal of Pharmacology. 592(1-3). 41–47. 20 indexed citations
19.
Boovanahalli, Shanthaveerappa K., Xuejun Jin, Yinglan Jin, et al.. (2007). Synthesis of (aryloxyacetylamino)-isonicotinic/nicotinic acid analogues as potent hypoxia-inducible factor (HIF)-1α inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(22). 6305–6310. 28 indexed citations
20.
Guan, Liping, et al.. (2005). Protective effects of chalcone derivatives for acute liver injury in mice. Archives of Pharmacal Research. 28(1). 81–86. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Duan‐Fang Liao Breakdown of academic impact, for papers by Xun Hu Breakdown of academic impact, for papers by Andrzej Stepulak Breakdown of academic impact, for papers by Xiaozhuo Chen Breakdown of academic impact, for papers by Jeong‐Hyung Lee Breakdown of academic impact, for papers by Acharan S. Narula Breakdown of academic impact, for papers by Gyu‐Yong Song Breakdown of academic impact, for papers by Takeshi Kumagai Breakdown of academic impact, for papers by Xiaojun Xu
Rankless by CCL
2026